Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France
JAMA Netw Open. 2022 Dec 1;5(12):e2247534.
doi: 10.1001/jamanetworkopen.2022.47534.
1 Hematology Department, Nantes University Hospital, Nantes, France.
2 Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche UMR1232, Centre de Recherche en Cancérologie et Immunologie Nantes-Angers, Institut de Recherche en Santé de l'Université de Nantes, University of Nantes, France.
3 Virology Department, Nantes University Hospital, Nantes, France.
4 Hematology Biology Department, Nantes University Hospital, Nantes, France.
This cohort study assesses the incidence and severity of COVID-19 among vaccinated recipients of allogenic stem cell transplant in a single center after 1 or 2 messenger RNA booster doses during the Omicron wave in France.